A Novel Approach to Prepare Insulin-Loaded Poly (Lactic-Co-Glycolic Acid) Microcapsules and the Protein Stability Study

被引:57
作者
Emami, Jaber [1 ]
Hamishehkar, Hamed [1 ,2 ]
Najafabadi, Abdolhossien Rouholamini [3 ,4 ]
Gilani, Kambiz [3 ]
Minaiyan, Mohsen [1 ]
Mahdavi, Hamid [5 ]
Nokhodchi, Ali [6 ,7 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Pharmaceut Res Ctr, Sch Pharm & Pharmaceut Sci, Esfahan, Iran
[2] Tabriz Univ Med Sci, Drug Appl Res Ctr, Pharmaceut Technol Lab, Tabriz, Iran
[3] Univ Tehran Med Sci, Sch Pharm, Aerosol Res Lab, Tehran, Iran
[4] Pasteur Inst Iran, Dept Nanobiotechnol, Tehran, Iran
[5] Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, Tehran, Iran
[6] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
[7] Univ Greenwich, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
关键词
poly(lactic-co-glycolic acid); protein/polypeptide encapsulation; protein stability; solvent evaporation; insulin; BOVINE SERUM-ALBUMIN; HUMAN GROWTH-HORMONE; IN-VITRO RELEASE; BIODEGRADABLE POLYESTER MICROSPHERES; SOLVENT EVAPORATION TECHNIQUE; COPOLYMER PLGA NANOSPHERES; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; POLY(ETHYLENE GLYCOL); SUSTAINED-RELEASE; ORGANIC-SOLVENTS;
D O I
10.1002/jps.21544
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The purpose of this study was to propose a new preparation method to fabricate insulin-loaded poly (lactic-coglycolic acid) (PLGA) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein. Insulin-loaded microcapsules were produced by a single phase c/o solvent evaporation method. The characteristics of the microcapsules were determined by various methods: the surface morphology and size of microparticles by atomic force microscopy and scanning electron microscopy, insulin crystalinity and drug-polymer interactions by XRD, DSC, and FTIR, chemical integrity and aggregation of insulin using H PLC and SDS-PAGE, the protein secondary structure by far ultraviolet-circular dichroism (CD), the antigenicity activity of insulin with ELISA techniques. PLGA microparticles showed smooth Surfaces with microcapsule. Encapsulation efficiency of 51% and constant insulin release rate with initial insulin burst release of 24% was obtained. Encapsulated and released insulin was in the intact form and it was dispersed in crystalline state in the polymer matrix. Ease of manufacturing under mild preparation conditions, high level of drug entrapment, desirable release pattern with relatively low initial burst effect and an ability to preserve protein structure are the advantages which are offered by the developed protein encapsulation method. (c) 2008 Wiley-Liss Inc. and the American Pharmacists Association J Pharm Sci 98:1712-1731, 2009
引用
收藏
页码:1712 / 1731
页数:20
相关论文
共 115 条
[1]
Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery [J].
Aguiar, MMG ;
Rodrigues, JM ;
Cunha, AS .
JOURNAL OF MICROENCAPSULATION, 2004, 21 (05) :553-564
[2]
PLG microsphere size controls drug release rate through several competing factors [J].
Berkland, C ;
Kim, K ;
Pack, DW .
PHARMACEUTICAL RESEARCH, 2003, 20 (07) :1055-1062
[3]
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (03) :375-388
[4]
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
AAPS PHARMSCITECH, 2005, 6 (04)
[5]
Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics [J].
Bittner, B ;
Morlock, M ;
Koll, H ;
Winter, G ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :295-305
[6]
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[7]
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[8]
Bloemendal M, 1995, Pharm Biotechnol, V7, P65
[9]
Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA [J].
Capan, Y ;
Woo, BH ;
Gebrekidan, S ;
Ahmed, S ;
DeLuca, PP .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :279-286
[10]
Rational design of stable lyophilized protein formulations: Some practical advice [J].
Carpenter, JF ;
Pikal, MJ ;
Chang, BS ;
Randolph, TW .
PHARMACEUTICAL RESEARCH, 1997, 14 (08) :969-975